Treatment of epidermolysis bullosa acquisita with the humanized anti-Tac mAb daclizumab
Epidermolysis bullosa acquisita (EBA) is an autoimmune subepidermal blistering disease characterized by IgG anti-basement membrane autoantibodies to collagen VII. Since autoantibody formation in EBA patients is thought to be T-cell-dependent, the degree of T cell activation in three patients (all ma...
| Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 101(2001), 2 vom: 01. Nov., Seite 146-51 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | , , |
| Format: | Aufsatz |
| Sprache: | English |
| Veröffentlicht: |
2001
|
| Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.) |
| Schlagworte: | Journal Article Research Support, U.S. Gov't, P.H.S. Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Epitopes Immunoglobulin G Immunosuppressive Agents Receptors, Interleukin-2 Daclizumab CUJ2MVI71Y |